Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

J Bellmunt; R Fougeray; J E Rosenberg; H von der Maase; F A Schutz; Y Salhi; S Culine; T K Choueiri

doi:10.1093/annonc/mdt007

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

J Bellmunt, R Fougeray, J E Rosenberg, H von der Maase, F A Schutz, Y Salhi, S Culine, T K Choueiri

Department of Gastroenterology

160 Citations (Scopus)

Abstract

To compare long-term, updated overall survival (OS) of patients with advanced transitional cell carcinoma of the urothelium (TCCU) treated with vinflunine plus best supportive care (BSC) or BSC alone, after failure of platinum-based chemotherapy.

Original language	English
Journal	Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
Volume	24
Issue number	6
Pages (from-to)	1466-72
Number of pages	7
ISSN	0923-7534
DOIs	https://doi.org/10.1093/annonc/mdt007
Publication status	Published - Jun 2013

Keywords

Aged
Carcinoma, Transitional Cell
Cisplatin
Female
Follow-Up Studies
Humans
Male
Middle Aged
Platinum Compounds
Prospective Studies
Survival Rate
Time Factors
Treatment Failure
Urinary Bladder Neoplasms
Urothelium
Vinblastine

Access to Document

10.1093/annonc/mdt007

Fingerprint

Dive into the research topics of 'Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy'. Together they form a unique fingerprint.

Cite this

Bellmunt, J., Fougeray, R., Rosenberg, J. E., von der Maase, H., Schutz, F. A., Salhi, Y., Culine, S., & Choueiri, T. K. (2013). Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 24(6), 1466-72. https://doi.org/10.1093/annonc/mdt007

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. / Bellmunt, J; Fougeray, R; Rosenberg, J E et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, Vol. 24, No. 6, 06.2013, p. 1466-72.

Research output: Contribution to journal › Journal article › Research › peer-review

Bellmunt, J, Fougeray, R, Rosenberg, JE, von der Maase, H, Schutz, FA, Salhi, Y, Culine, S & Choueiri, TK 2013, 'Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy', Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, vol. 24, no. 6, pp. 1466-72. https://doi.org/10.1093/annonc/mdt007

Bellmunt J, Fougeray R, Rosenberg JE, von der Maase H, Schutz FA, Salhi Y et al. Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Jun;24(6):1466-72. doi: 10.1093/annonc/mdt007

Bellmunt, J ; Fougeray, R ; Rosenberg, J E et al. / Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy. In: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 ; Vol. 24, No. 6. pp. 1466-72.

@article{c4511b0b6cdc4878a3c561477dc609c1,

title = "Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy",

abstract = "To compare long-term, updated overall survival (OS) of patients with advanced transitional cell carcinoma of the urothelium (TCCU) treated with vinflunine plus best supportive care (BSC) or BSC alone, after failure of platinum-based chemotherapy.",

keywords = "Aged, Carcinoma, Transitional Cell, Cisplatin, Female, Follow-Up Studies, Humans, Male, Middle Aged, Platinum Compounds, Prospective Studies, Survival Rate, Time Factors, Treatment Failure, Urinary Bladder Neoplasms, Urothelium, Vinblastine",

author = "J Bellmunt and R Fougeray and Rosenberg, \{J E\} and \{von der Maase\}, H and Schutz, \{F A\} and Y Salhi and S Culine and Choueiri, \{T K\}",

year = "2013",

month = jun,

doi = "10.1093/annonc/mdt007",

language = "English",

volume = "24",

pages = "1466--72",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology / ESMO",

issn = "0923-7534",

publisher = "Elsevier Limited",

number = "6",

}

TY - JOUR

T1 - Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

AU - Bellmunt, J

AU - Fougeray, R

AU - Rosenberg, J E

AU - von der Maase, H

AU - Schutz, F A

AU - Salhi, Y

AU - Culine, S

AU - Choueiri, T K

PY - 2013/6

Y1 - 2013/6

N2 - To compare long-term, updated overall survival (OS) of patients with advanced transitional cell carcinoma of the urothelium (TCCU) treated with vinflunine plus best supportive care (BSC) or BSC alone, after failure of platinum-based chemotherapy.

AB - To compare long-term, updated overall survival (OS) of patients with advanced transitional cell carcinoma of the urothelium (TCCU) treated with vinflunine plus best supportive care (BSC) or BSC alone, after failure of platinum-based chemotherapy.

KW - Aged

KW - Carcinoma, Transitional Cell

KW - Cisplatin

KW - Female

KW - Follow-Up Studies

KW - Humans

KW - Male

KW - Middle Aged

KW - Platinum Compounds

KW - Prospective Studies

KW - Survival Rate

KW - Time Factors

KW - Treatment Failure

KW - Urinary Bladder Neoplasms

KW - Urothelium

KW - Vinblastine

UR - https://www.scopus.com/pages/publications/84878442860

U2 - 10.1093/annonc/mdt007

DO - 10.1093/annonc/mdt007

M3 - Journal article

C2 - 23419284

SN - 0923-7534

VL - 24

SP - 1466

EP - 1472

JO - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

JF - Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

IS - 6

ER -

Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this